Equine Healthcare Market - Global Industry Analysis

Equine Healthcare Market by Product (Drugs, Vaccines and Supplemental Feed Additives) by Disease (West Nile Virus, Equine Rabies, Equine Influenza, Equine Herpes Virus, Potomac Horse Fever and Others), by Distribution Channel (Veterinary Hospitals and Clinics, Retail Pharmacies and Drug Stores and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2023

Published Date: 26-Apr-2018 Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-2813 Status : Published

Global equine healthcare market expected to generate revenue of around USD 752.76 million by end of 2023, growing at a CAGR of around 3.80% between 2017 and 2023. Equine health refers to veterinary services intended to treat horses to enhance their quality of life. The equine healthcare market is an emerging field of pharmaceuticals.

Description

The report covers forecast and analysis for the equine healthcare market on a global and regional level. The study provides historic data of 2017 along with a forecast from 2018 to 2023 based revenue (USD Million). The study includes drivers and restraints for the equine healthcare market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the equine healthcare market on a global level. In order to give the users of this report a comprehensive view on the equine healthcare market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein product type segment, disease type segment and distribution channel segment are benchmarked based on their market size, growth rate, and general attractiveness. 

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, research & development, technology and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, the product portfolio of various companies according to the region.

Global Equine Healthcare Market

The study provides a decisive view on the equine healthcare market by segmenting the market based on product type, disease type, by distribution channel and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2017 to 2023. Based on product type the market is segmented into drug type, vaccine type, and supplemental feed additives. Based on disease type the market is segmented into west nile virus, equine rabies, equine influenza, equine herpes virus, potomac horse fever and others category. Based on distribution channel the market is segmented into veterinary hospitals and clinics, retail pharmacies and drug stores and others category. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and the Middle East & Africa with its further bifurcation into major countries. This segmentation includes demand for equine healthcare market based on product type, disease type and distribution channel in all the regions and countries.

The report also includes detailed profiles of end players such as Bayer AG (Bayer Animal Health), Boehringer Ingelheim, Ceva Santé Animale, Eli Lilly and Company (Elanco), Equine Products U.K. Ltd., Merck & Co. (Merck Animal Health), Sanofi (Merial), Purina Animal Nutrition LLC, Vetoquinol S.A., Zoetis and Others.

This report segments the global equine healthcare market as follows:

Global Equine Healthcare Market: Product Type Segment Analysis

  • Drug Type
    • Anti-Infectives
    • Anti-Inflammatory
    • Parasiticides
    • Others
  • Vaccine Type
    • Inactivated
    • Live Attenuated
    • Recombinant
    • Others
  • Supplemental Feed Additives

Global Equine Healthcare Market: Diseases Segment Analysis

  • West Nile Virus
  • Equine Rabies
  • Equine Influenza
  • Equine Herpes Virus 
  • Potomac Horse Fever 
  • Others

Global Equine Healthcare Market: Distribution Channel Method Analysis

  • Veterinary Hospitals And Clinics
  • Retail Pharmacies And Drug Stores
  • Others

Global Equine Healthcare Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global equine healthcare market, 2017 – 2023 (USD Million)
    • 2.2. Global equine healthcare market: snapshot
  •  
  • Chapter 3. Equine Healthcare Market– Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Global equine healthcare market drivers: impact analysis
      • 3.2.2. Rising incidence of equine infections
      • 3.2.3. Initiatives by equine healthcare organizations and market participants
    • 3.3. Market Restraints
      • 3.3.1. Global equine healthcare market restraints: impact analysis
      • 3.3.2. The decline in global equine population
    • 3.4. Opportunities
      • 3.4.1. The rise in demand for pet insurance
    • 3.5. Porter’s five forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. The threat from new entrants
      • 3.5.4. Threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis, by product type segment
      • 3.6.2. Market attractiveness analysis, by diseases type segment
      • 3.6.3. Market attractiveness analysis, by distribution channel segment
      • 3.6.4. Market attractiveness analysis, by regional segment
  •  
  • Chapter 4. Global Equine Healthcare Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global equine healthcare market: company market share, 2017
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New therapy launch
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
    • 4.3. Price trend analysis
  •  
  • Chapter 5. Global Equine Healthcare Market– Product Type Analysis
    • 5.1. Global equine healthcare market: Product type overview
      • 5.1.1. Global equine healthcare market revenue share, by product type, 2017 and 2023
    • 5.2. Drug Type
      • 5.2.1. Global equine healthcare market for drug type, 2017 – 2023 (USD Million)
        • 5.2.1.1. Anti-Infectives
          • 5.2.1.1.1. Global anti-infectives market, 2016 – 2022 (USD Million)
        • 5.2.1.2. Anti-Inflammatory
          • 5.2.1.2.1. The global anti-inflammatory market, 2016 – 2022 (USD Million)
        • 5.2.1.3. Parasiticides
          • 5.2.1.3.1. Global parasiticides market, 2016 – 2022 (USD Million)
        • 5.2.1.4. Others
          • 5.2.1.4.1. Global others market, 2016 – 2022 (USD Million)
    • 5.3. Vaccine Type
      • 5.3.1. Global equine healthcare market for vaccine type, 2017 – 2023 (USD Million)
        • 5.3.1.1. Inactivated
          • 5.3.1.1.1. Global inactivated market, 2016 – 2022 (USD Million)
        • 5.3.1.2. Live Attenuated
          • 5.3.1.2.1. Global live attenuated market, 2016 – 2022 (USD Million)
        • 5.3.1.3. Recombinant
          • 5.3.1.3.1. Global recombinant market, 2016 – 2022 (USD Million)
        • 5.3.1.4. Others
          • 5.3.1.4.1. Global others market, 2016 – 2022 (USD Million)
    • 5.4. Supplemental Feed Additives
      • 5.4.1. Global equine healthcare market for supplemental feed additives, 2017 – 2023 (USD Million)
  •  
  • Chapter 6. Global Equine Healthcare Market– Diseases Type Analysis
    • 6.1. Global equine healthcare market: Diseases type overview
      • 6.1.1. Global equine healthcare market revenue share, by disease type, 2017 and 2023
    • 6.2. West Nile Virus
      • 6.2.1. Global equine healthcare market for west nile virus, 2017 – 2023 (USD Million)
    • 6.3. Equine Influenza
      • 6.3.1. Global equine healthcare market for equine influenza, 2017 – 2023 (USD Million)
    • 6.4. Equine Herpes Virus
      • 6.4.1. Global equine healthcare market for equine herpes virus, 2017 – 2023 (USD Million)
    • 6.5. Potomac Horse Fever
      • 6.5.1. Global equine healthcare market for potomac horse fever, 2017 – 2023 (USD Million)
    • 6.6. Others
      • 6.6.1. Global equine healthcare market for others, 2017 – 2023 (USD Million)
  •  
  • Chapter 7. Global Equine Healthcare Market– Distribution Channel Analysis
    • 7.1. Global equine healthcare market: distribution channel overview
      • 7.1.1. Global equine healthcare market revenue share, by distribution channel, 2017 and 2023
    • 7.2. Veterinary Hospitals and Clinics
      • 7.2.1. Global equine healthcare market for veterinary hospitals and clinics, 2017 – 2023 (USD Million)
    • 7.3. Retail Pharmacies and Drug Stores
      • 7.3.1. Global equine healthcare market for retail pharmacies and drug stores, 2017 – 2023 (USD Million)
    • 7.4. Others
      • 7.4.1. Global equine healthcare market for others, 2017 – 2023 (USD Million)
  •  
  • Chapter 8. Global Equine Healthcare Market– Regional Segment Analysis
    • 8.1. Global equine healthcare market: regional overview
      • 8.1.1. Global equine healthcare market revenue share, by region, 2017 and 2023
    • 8.2. North America
      • 8.2.1. North America equine healthcare market revenue, by product type, 2017 – 2023 (USD Million)
      • 8.2.2. North America equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
      • 8.2.3. North America equine healthcare market revenue, by distribution channel, 2017 – 2023 (USD Million)
      • 8.2.4. U.S.
        • 8.2.4.1. U.S. equine healthcare market revenue, by product type, 2017 – 2023 (USD Million)
        • 8.2.4.2. U.S. equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
        • 8.2.4.3. U.S. equine healthcare market revenue, by distribution channel, 2017 – 2023 (USD Million)
      • 8.2.5. Rest of North America
        • 8.2.5.1. Rest of North America equine healthcare market revenue, by product type, 2017 – 2023 (USD Million)
        • 8.2.5.2. Rest of North America equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
        • 8.2.5.3. Rest of North America equine healthcare market revenue, by distribution channel, 2017 – 2023 (USD Million)
    • 8.3. Europe
      • 8.3.1. Europe equine healthcare market revenue, by product type, 2017 – 2023 (USD Million)
      • 8.3.2. Europe equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
      • 8.3.3. Europe equine healthcare market revenue, by distribution channel, 2017 – 2023 (USD Million)
      • 8.3.4. U.K.
        • 8.3.4.1. U.K. equine healthcare market revenue, by product type, 2017 – 2023 (USD Million)
        • 8.3.4.2. U.K. equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
        • 8.3.4.3. U.K. equine healthcare market revenue, by distribution channel, 2017 – 2023 (USD Million)
      • 8.3.5. Germany
        • 8.3.5.1. Germany equine healthcare market revenue, by product type, 2017 – 2023 (USD Million)
        • 8.3.5.2. Germany equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
        • 8.3.5.3. Germany equine healthcare market revenue, by distribution channel, 2017 – 2023 (USD Million)
      • 8.3.6. France
        • 8.3.6.1. France equine healthcare market revenue, by product type, 2017 – 2023 (USD Million)
        • 8.3.6.2. France equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
        • 8.3.6.3. France equine healthcare market revenue, by distribution channel, 2017 – 2023 (USD Million)
      • 8.3.7. Rest of Europe
        • 8.3.7.1. Rest of Europe equine healthcare market revenue, by product type, 2017 – 2023 (USD Million)
        • 8.3.7.2. Rest of Europe equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
        • 8.3.7.3. Rest of Europe equine healthcare market revenue, by distribution channel, 2017 – 2023 (USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific equine healthcare market revenue, by product type, 2017 – 2023 (USD Million)
      • 8.4.2. Asia Pacific equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
      • 8.4.3. Asia Pacific equine healthcare market revenue, by distribution channel, 2017 – 2023 (USD Million)
      • 8.4.4. China
        • 8.4.4.1. China equine healthcare market revenue, by product type, 2017 – 2023 (USD Million)
        • 8.4.4.2. China equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
        • 8.4.4.3. China equine healthcare market revenue, by distribution channel, 2017 – 2023 (USD Million)
      • 8.4.5. Japan
        • 8.4.5.1. Japan equine healthcare market revenue, by product type, 2017 – 2023 (USD Million)
        • 8.4.5.2. Japan equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
        • 8.4.5.3. Japan equine healthcare market revenue, by distribution channel, 2017 – 2023 (USD Million)
      • 8.4.6. India
        • 8.4.6.1. India equine healthcare market revenue, by product type, 2017 – 2023 (USD Million)
        • 8.4.6.2. India equine healthcare market revenue, by diseases, 2017 – 2023 (USD Million)
        • 8.4.6.3. India equine healthcare market revenue, by distribution channel, 2017 – 2023 (USD Million)
      • 8.4.7. Rest of Asia Pacific
        • 8.4.7.1. Rest of Asia Pacific equine healthcare market revenue, by product type, 2017 – 2023 (USD Million)
        • 8.4.7.2. Rest of Asia Pacific equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
        • 8.4.7.3. Rest of Asia Pacific equine healthcare market revenue, by distribution channel, 2017 – 2023 (USD Million)
    • 8.5. Latin America
      • 8.5.1. Latin America equine healthcare market revenue, by product type, 2017 – 2023 (USD Million)
      • 8.5.2. Latin America equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
      • 8.5.3. Latin America equine healthcare market revenue, by distribution channel, 2017 – 2023 (USD Million)
      • 8.5.4. Brazil
        • 8.5.4.1. Brazil equine healthcare market revenue, by product type, 2017 – 2023 (USD Million)
        • 8.5.4.2. Brazil equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
        • 8.5.4.3. Brazil equine healthcare market revenue, by distribution channel, 2017 – 2023 (USD Million)
      • 8.5.5. Mexico
        • 8.5.5.1. Mexico equine healthcare market revenue, by product type, 2017 – 2023 (USD Million)
        • 8.5.5.2. Mexico equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
        • 8.5.5.3. Mexico equine healthcare market revenue, by distribution channel, 2017 – 2023 (USD Million)
      • 8.5.6. Rest of Latin America
        • 8.5.6.1. Rest of Latin America equine healthcare market revenue, by product type, 2017 – 2023 (USD Million)
        • 8.5.6.2. Rest of Latin America equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
        • 8.5.6.3. Rest of Latin America equine healthcare market revenue, by distribution channel, 2017 – 2023 (USD Million)
    • 8.6. Middle East and Africa
      • 8.6.1. Middle East and Africa equine healthcare market revenue, by product type, 2017 – 2023 (USD Million)
      • 8.6.2. Middle East and Africa equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
      • 8.6.3. Middle East and Africa equine healthcare market revenue, by distribution channel, 2017 – 2023 (USD Million)
      • 8.6.4. Saudi Arabia
        • 8.6.4.1. Saudi Arabia equine healthcare market revenue, by product type, 2017 – 2023 (USD Million)
        • 8.6.4.2. Saudi Arabia equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
        • 8.6.4.3. Saudi Arabia equine healthcare market revenue, by distribution channel, 2017 – 2023 (USD Million)
      • 8.6.5. UAE
        • 8.6.5.1. UAE equine healthcare market revenue, by product type, 2017 – 2023 (USD Million)
        • 8.6.5.2. UAE equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
        • 8.6.5.3. UAE equine healthcare market revenue, by distribution channel, 2017 – 2023 (USD Million)
      • 8.6.6. South Africa
        • 8.6.6.1. South Africa equine healthcare market revenue, by product type, 2017 – 2023 (USD Million)
        • 8.6.6.2. South Africa equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
        • 8.6.6.3. South Africa equine healthcare market revenue, by distribution channel, 2017 – 2023 (USD Million)
      • 8.6.7. Rest of Middle East and Africa
        • 8.6.7.1. Rest of Middle East and Africa equine healthcare market revenue, by product type, 2017 – 2023 (USD Million)
        • 8.6.7.2. Rest of Middle East and Africa equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
        • 8.6.7.3. Rest of Middle East and Africa equine healthcare market revenue, by distribution channel, 2017 – 2023 (USD Million)
  •  
  • Chapter 9. Company Profiles
    • 9.1. Bayer AG (Bayer Animal Health)
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Therapy portfolio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. Boehringer Ingelheim
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Therapy portfolio
      • 9.2.4. Business strategy
      • 9.2.5. Recent developments
    • 9.3. Ceva Santé Animale
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Therapy portfolio
      • 9.3.4. Business strategy
      • 9.3.5. Recent developments
    • 9.4. Eli Lilly and Company (Elanco)
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Therapy portfolio
      • 9.4.4. Business strategy
      • 9.4.5. Recent developments
    • 9.5. Equine Products U.K. Ltd.
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Therapy portfolio
      • 9.5.4. Business strategy
      • 9.5.5. Recent developments
    • 9.6. Merck & Co. (Merck Animal Health)
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Therapy portfolio
      • 9.6.4. Business strategy
      • 9.6.5. Recent developments
    • 9.7. Sanofi (Merial)
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Therapy portfolio
      • 9.7.4. Business strategy
      • 9.7.5. Recent developments
    • 9.8. Purina Animal Nutrition LLC]
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Therapy portfolio
      • 9.8.4. Business strategy
      • 9.8.5. Recent developments
    • 9.9. Vetoquinol S.A.
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Therapy portfolio
      • 9.9.4. Business strategy
      • 9.9.5. Recent developments
    • 9.10. Zoetis
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Therapy portfolio
      • 9.10.4. Business strategy
      • 9.10.5. Recent developments

Table Of Figures

List of Figures 

1. Market research process
2. Market research methodology
3. Global equine healthcare market revenue, 2017 – 2023 (USD Million) 
4. Porter’s five forces analysis
5. Equine healthcare market: market attractiveness analysis, by product type
6. Equine healthcare market: market attractiveness analysis, by diseases type
7. Equine healthcare market: market attractiveness analysis, by distribution channel type
8. Equine healthcare market: market attractiveness analysis, by regional segment
9. Company market share analysis, 2017 
10. Global equine healthcare market revenue share by technology type, 2017 and 2023
11. Global equine healthcare market for cell-based, 2017 – 2023 (USD Million)
12. Global equine healthcare market for bead-based, 2017 – 2023 (USD Million)
13. Global equine healthcare market revenue share by product type, 2017 and 2023
14. Global equine healthcare market for drugs, 2017 – 2023, (USD Million) 
15. Global equine healthcare market for vaccines, 2017 – 2023, (USD Million) 
16. Global equine healthcare market for supplemental feed additives, 2017 – 2023, (USD Million)
17. Global equine healthcare market revenue share by diseases type, 2017 and 2023
18. Global equine healthcare market for west nile virus, 2017 – 2023, (USD Million) 
19. Global equine healthcare market for equine rabies, 2017 – 2023, (USD Million) 
20. Global equine healthcare market for equine influenza, 2017 – 2023, (USD Million)
21. Global equine healthcare market for equine herpes virus, 2017 – 2023, (USD Million)
22. Global equine healthcare market for equine potomac horse fever, 2017 – 2023, (USD Million)
23. Global equine healthcare market for others, 2017 – 2023, (USD Million)
24. Global equine healthcare market revenue share by distribution channel type, 2017 and 2023
25. Global equine healthcare market for veterinary hospitals and clinics, 2017 – 2023, (USD Million) 
26. Global equine healthcare market for retail pharmacies and drug stores, 2017 – 2023, (USD Million) 
27. Global equine healthcare market for others, 2017 – 2023, (USD Million)


Table Of Tables

List of Tables

1. Equine healthcare market: market snapshot  
2. Drivers of global equine healthcare market: impact analysis 
3. Restraints of global equine healthcare market: impact analysis  
4. North America equine healthcare market revenue, by product type, 2017 – 2023 (USD Million) 
5. North America equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
6. North America equine healthcare market revenue, by distribution channel type, 2017 – 2023 (USD Million)
7. U.S. equine healthcare market revenue, by product type, 2017 – 2023 (USD Million)
8. U.S. equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
9. U.S. equine healthcare market revenue, by distribution channel type, 2017 – 2023 (USD Million)
10. Rest of North America equine healthcare market revenue, by product type, 2017 – 2023 (USD Million)
11. Rest of North America equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
12. Rest of North America equine healthcare market revenue, by distribution channel type, 2017 – 2023 (USD Million)
13. Europe equine healthcare market revenue, by product type, 2017 – 2023 (USD Million)
14. Europe equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
15. Europe equine healthcare market revenue, by distribution channel type, 2017 – 2023 (USD Million) 
16. U.K. equine healthcare market revenue, by product type, 2017 – 2023 (USD Million)
17. U.K. equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
18. U.K. equine healthcare market revenue, by distribution channel type, 2017 – 2023 (USD Million)
19. Germany equine healthcare market revenue, by product type, 2017 – 2023 (USD Million)
20. Germany equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
21. Germany equine healthcare market revenue, by distribution channel type, 2017 – 2023 (USD Million)
22. France equine healthcare market revenue, by product type, 2017 – 2023 (USD Million)
23. France equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
24. France equine healthcare market revenue, by distribution channel type, 2017 – 2023 (USD Million)
25. Rest of Europe equine healthcare market revenue, by product type, 2017 – 2023 (USD Million)
26. Rest of Europe equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
27. Rest of Europe equine healthcare market revenue, by distribution channel type, 2017 – 2023 (USD Million)
28. Asia Pacific equine healthcare market revenue, by product type, 2017 – 2023 (USD Million) 
29. Asia Pacific equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
30. Asia Pacific equine healthcare market revenue, by distribution channel type, 2017 – 2023 (USD Million)
31. China equine healthcare market revenue, by product type, 2017 – 2023 (USD Million)
32. China equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
33. China equine healthcare market revenue, by distribution channel type, 2017 – 2023 (USD Million)
34. Japan equine healthcare market revenue, by product type, 2017 – 2023 (USD Million)
35. Japan equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
36. Japan equine healthcare market revenue, by distribution channel type, 2017 – 2023 (USD Million)
37. India equine healthcare market revenue, by product type, 2017 – 2023 (USD Million) 
38. India equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
39. India equine healthcare market revenue, by distribution channel type, 2017 – 2023 (USD Million)
40. Rest of Asia Pacific equine healthcare market revenue, by product type, 2017 – 2023 (USD Million)
41. Rest of Asia Pacific equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
42. Rest of Asia Pacific equine healthcare market revenue, by distribution channel type, 2017 – 2023 (USD Million)
43. Latin America equine healthcare market revenue, by product type, 2017 – 2023 (USD Million) 
44. Latin America equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
45. Latin America equine healthcare market revenue, by distribution channel type, 2017 – 2023 (USD Million)
46. Brazil equine healthcare market revenue, by product type, 2017 – 2023 (USD Million) 
47. Brazil equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
48. Brazil equine healthcare market revenue, by distribution channel type, 2017 – 2023 (USD Million)
49. Mexico equine healthcare market revenue, by product type, 2017 – 2023 (USD Million)
50. Mexico equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
51. Mexico equine healthcare market revenue, by distribution channel type, 2017 – 2023 (USD Million)
52. Rest of Latin America equine healthcare market revenue, by product type, 2017 – 2023 (USD Million)
53. Rest of Latin America equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
54. Rest of Latin America equine healthcare market revenue, by distribution channel type, 2017 – 2023 (USD Million)
55. Middle East and Africa equine healthcare market revenue, by product type, 2017 – 2023 (USD Million)
56. Middle East and Africa equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
57. Middle East and Africa equine healthcare market revenue, by distribution channel type, 2017 – 2023 (USD Million)
58. Saudi Arabia equine healthcare market revenue, by product type, 2017 – 2023 (USD Million)
59. Saudi Arabia equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
60. Saudi Arabia equine healthcare market revenue, by distribution channel type, 2017 – 2023 (USD Million)
61. UAE equine healthcare market revenue, by product type, 2017 – 2023 (USD Million)
62. UAE equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
63. UAE equine healthcare market revenue, by distribution channel type, 2017 – 2023 (USD Million)
64. South Africa equine healthcare market revenue, by product type, 2017 – 2023 (USD Million)
65. South Africa equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
66. South Africa equine healthcare market revenue, by distribution channel type, 2017 – 2023 (USD Million)
67. Rest of Middle East and Africa equine healthcare market revenue, by product type, 2017 – 2023 (USD Million)
68. Rest of Middle East and Africa equine healthcare market revenue, by diseases type, 2017 – 2023 (USD Million)
69. Rest of the Middle East and Africa equine healthcare market revenue, by distribution channel type, 2017 – 2023 (USD Million)

Methodology

Free Analysis

Equine has been used since long for transportation, warfare and farming purposes. Today, they are used as police horses, recreation, racing, and entertainment. Horse serum is used to develop a variety of vaccines and antitoxins to treat several infectious diseases including botulism, rabies, diphtheria, and infection from H5N1 influenza. Equine industry has greater economic effect in countries like United States, Australia, and New Zealand as they generate a huge amount of revenue. American Horse Council reveals that at present there are 9.2 million horses across the nation involving approximately 4.6 million people as horse owners, caretakers, employees, and volunteers.

Equine veterinary practice is expected to be a high overhead owing to prevent the rising diseases like influenza virus, herpes virus, west nile virus, and encephalomyelitis, where the cost for global vaccination is estimated to be around 31 million dollars by the Euro Surveillance Journal in 2016. Rising investments and popularity in alternative forms of gambling like horse racing, online gaming, betting, competitive riding, high return on investment and leisure is expected to drive the global equine healthcare market. Additionally, the growth initiatives by equine healthcare organizations to develop drugs for various diseases are expected to give impetus to the equine healthcare market.

Based on product type the market is segmented into drug type, vaccine type, and supplemental feed additives. The drug type segment is expected to propel the market in the forecast period. Based on disease type the market is segmented into west nile virus, equine rabies, equine influenza, equine herpes virus, potomac horse fever and others category. The equine influenza and herpes virus is expected to drive the market growth among disease type category in the forecast period. Based on distribution channel the market is segmented into veterinary hospitals and clinics, retail pharmacies and drug stores and others category.

Global Equine Healthcare Market

The Australian market is among the leading horse breeding countries of Asia Pacific, hence contributing to the drastically increased demand for healthcare products in the Asia Pacific. Additionally, the maintenance of race-horse breeds by the rising investments from China by specific supplements, therapeutic and protection products is thriving the growth of Asia Pacific market globally. Also, according to a study conducted by the American Horse Council, U.S. has 9.2 million horses with $39 billion direct economic impacts. Also, a total 22,849 horses were imported into the U.S. in 2013, thereby increasing the demand of equine healthcare in North America.

Some of the key players in the equine healthcare market are Bayer AG (Bayer Animal Health), Boehringer Ingelheim, Ceva Santé Animale, Eli Lilly and Company (Elanco), Equine Products U.K. Ltd., Merck & Co. (Merck Animal Health), Sanofi (Merial), Purina Animal Nutrition LLC, Vetoquinol S.A., and Zoetis.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed